Debio-1454

N/A

Report date: 2024/11/29 11:23:40
NME

Base Information

Drug NameDebio-1454
Drug Alias NameDebio-1454/SDebio-1454
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEnoyl-[acyl-carrier-protein] reductase [NADPH] FabL inhibitors
TargetsEnoyl-[acyl-carrier-protein] reductase [NADPH] FabL
Therapy Area/IndicationsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDebiopharm International Sa
China Registration ClassN/A

Develop Information

Active CompaniesDebiopharm International Sa
Inactive CompaniesN/A
Active IndicationsGram-Negative Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A